Impact of intravitreal anti-VEGF therapy on intraretinal microvascular abnormalities in proliferative diabetic retinopathy

Acta Diabetol. 2024 Apr;61(4):525-528. doi: 10.1007/s00592-023-02227-4. Epub 2024 Feb 1.

Authors

Daniele De Geronimo¹, Mariacristina Parravano², Riccardo Sacconi³, Serena Fragiotta⁴, Daniela Giannini¹, Eliana Costanzo¹, Monica Varano¹, Giuseppe Querques³

Affiliations

¹ IRCCS - Fondazione Bietti, Rome, Italy.
² IRCCS - Fondazione Bietti, Rome, Italy. mariacristina.parravano@fondazionebietti.it.
³ Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.
⁴ Department NESMOS, Ophthalmology Unit, S. Andrea Hospital, University of Rome "La Sapienza", Rome, Italy.

PMID: 38302784
DOI: 10.1007/s00592-023-02227-4

No abstract available

Keywords: Anti-VEGF; Diabetic retinopathy; IRMA; OCT angiography.

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Diabetes Mellitus* / drug therapy
Diabetic Retinopathy* / drug therapy
Fluorescein Angiography
Humans
Intravitreal Injections
Retinal Vessels
Tomography, Optical Coherence

Substances

Angiogenesis Inhibitors